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Abstract
Background: Insulin responses and insulin levels seem to decline with age. However, the question of beta cell
impairment attributable to ageing has been sparsely addressed in population-based studies. Non-fasting insulin
levels are determined by the ambient degree of insulin resistance together with the capacity of beta cells to
compensate by insulin secretion to prevent hyperglycaemia. A raised proinsulin-to-insulin ratio (proinsulin/insulin)
due to impaired processing of proinsulin is an early marker of beta cell dysfunction. We hypothesised that in a
general population, signs of beta cell failure with advancing age manifest not only by decreases in random insulin,
but also with a corresponding increase in its precursor proinsulin.
Methods: In the Tromsø Study 1994-95 we measured insulin and proinsulin concentrations in random blood
samples from 6212 persons without self-reported diabetes mellitus and plotted the levels as percentiles according
to age. In regression analyses we assessed the relationships between age and insulin, proinsulin, and proinsulin/
insulin, while adjusting for the concomitant measurements of glucose and other metabolic variables, and the time
since the last meal.
Results: Median insulin concentrations declined significantly with advancing age group in men, but not in women.
Proinsulin levels and proinsulin/insulin increased across age groups in both genders. After adjustment, greater age
was associated with lower log10(insulin) and higher log10(proinsulin) and log10(proinsulin/insulin) (p = 0.0001 for
all).
Conclusions: Negative associations of age with random insulin levels, together with positive associations of age
with proinsulin and proinsulin/insulin, point towards a loss of beta cell function inherent in the ageing process.
Background
T h ep r e v a l e n c eo fa b n o r m a lg lucose tolerance and dia-
betes mellitus increases with age [1-3]. For example, the
age-specific prevalences of diabetes in Europe were less
than 10% in subjects younger than 60 years, but
between 10 and 20% in subjects 60-79 years of age [3].
A prerequisite for the development of impaired glucose
tolerance (IGT) and type 2 diabetes is a decline in the
capacity of the islet cells to secrete insulin. This dete-
r i o r a t i o no fb e t ac e l lf u n c t i o np r e v e n t sa na d e q u a t eu p -
regulation of insulin secretion to compensate for insulin
resistance [4].
Insulin release is reported to diminish with increasing
age [5]. This decrease could involve a reduction in islet
mass, but could also be caused by a functional impair-
ment of the beta cells with ageing. A decline in post-
challenge insulin levels with advancing age has been
observed in population studies [6,7]. Although this find-
ing could reflect beta cell failure in ageing, it might also
be due to alterations in diet or gastric emptying, or even
to an enhancement in insulin sensitivity in older age.
Although proinsulin levels increase together with insulin
concentrations in insulin resistance [8], a raised ratio of
proinsulin to insulin, due to a disproportionate release
of proinsulin from beta cells, is considered an early mar-
ker of islet dysfunction [4].
In 6212 men and women who had random measure-
ments of insulin and proinsulin in a population-based
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describe the percentiles of insulin and proinsulin levels
and the proinsulin-to-insulin insulin ratio (proinsulin/
insulin) according to gender and age. In the same per-
sons we considered the influence of age on insulin,
proinsulin, and the proinsulin/insulin ratio, after adjust-
ment for the concomitant glucose concentrations, sev-
eral covariates associated with insulin resistance, and the
time since the last meal. Our hypothesis was that in a
general population, signs of deterioration of beta cell
function with advancing age is indicated not only by a
decrease in random insulin levels, but also by a corre-
sponding increase in proinsulin and proinsulin/insulin.
Methods
The Tromsø Study
The Tromsø Study was commenced in 1974 as a single
centre prospective follow-up study of inhabitants in the
municipality of Tromsø, with the primary objective to
study cardiovascular risk factors. The fourth survey of
the Tromsø Study [9] started in September 1994 and
was completed in October 1995. The regional ethics
committee approved the study and all subjects gave
written informed consent. The study comprised two
screening visits 4-12 weeks apart. All inhabitants older
than 24 years were invited to the first visit (Phase 1) by
a mailed letter, and 27,159 subjects (77% of the eligible
population) attended. This examination included stan-
dardised measurements of height, weight, blood pres-
sure, non-fasting serum lipids, serum calcium, g-
glutamyl transferase, haemoglobin and blood counts,
and a 20-second ECG recording of lead I. All subjects
aged 55-74 years and random 5-10% samples of the
other age groups who attended the first examination
w e r ei n v i t e dt oas e c o n dv i s i t( P h a s e2 )f o ram o r e
extensive screening, and 7965 subjects attended (93% of
those invited at Phase 1). This sample included women
who had been invited separately for a study of osteo-
porosis [10] and persons who had participated in a
family intervention trial [11].
Study subjects
At the Phase 2 visit, 7407 persons (3177 men and 4230
women) provided blood samples that included insulin
and proinsulin. One male and one female attendee with
plasma insulin <6 pmol L
-1 were excluded. We excluded
957 women who had been invited separately to a study
of osteoporosis [10]. Among these, 863 women aged 50-
54 years were excluded as they were all examined
between 08 and 09 AM, and the time from the last meal
had not been recorded, and 94 (aged 25-34 years) were
excluded because the handling of their blood samples
was inadequate. Of the remaining, 111 men and 115
women were excluded due to self-reported diabetes
mellitus or use of hypoglycaemic agents. The final
sample included 6212 persons, of whom1116 had parti-
cipated in a family intervention trial [11].
Questionnaires
The first questionnaire (Additional file 1) was mailed
with the invitation to participate in the study and was
returned at the Phase 1 visit. A second questionnaire
which differed in persons younger or older than
70 years (Additional files 2 and 3) was handed out at
the Phase 1 visit, and returned by post. The first ques-
tionnaire inquired about whether the respondents had
an established diagnosis of myocardial infarction, angina
pectoris, or diabetes. Self-reported current smoking
(cigarettes, cigars or pipe tobacco) and present antihy-
pertensive medication were also inquired. Coffee con-
sumption was registered as number of cups per day,
alcohol intake as glasses per fortnight, and frequency of
alcohol intake as occasions per month. A positive
response to the question “are you a teetotaller” was
taken as total abstinence from alcohol. Level of strenu-
ous and light leisure-time physical activity was graded
according to hours of activity resulting and not resulting
in perspiration or breathlessness during an average
week. The second questionnaire had questions about
the use of hypoglycaemic agents.
Examination at Phase 2
Height, weight, and waist and hip circumferences were
measured with the subjects standing and wearing light
clothing and no shoes, and body mass index (BMI) was
calculated. Waist circumferences were measured at the
umbilical line and hip girths at the widest circumfer-
ences, according to a written protocol. Blood pressure
and heart rate (Dinamap Vital Signs Monitor 1846, Cri-
ticon Inc., Tampa, FL, USA) were recorded in a sepa-
rate, quiet room before blood sampling. After the
participants had been seated for 2 min, three measure-
m e n t sw e r em a d ea t2 - m i ni n t e r v a l sa n dt h em e a no f
the last two recordings used in the analyses. A nurse
inquired again about diabetes, and use of medications in
the preceding week, and the time from the last meal
were recorded. Persons who reported that they took
insulin or oral hypoglycaemic agents were also consid-
ered to have diabetes mellitus. Non-fasting venous
blood samples were drawn between 0800 and 1600 h in
seated persons. A brief venous stasis was released before
sampling.
Analytical methods
Serum insulin was measured by radioimmunoassay [12].
The insulin antibody had less than 0.2% cross-reactivity
with proinsulin or its primary circulating split form,
des (31,32)-proinsulin. Serum intact proinsulin was
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Ltd., Cambridgeshire, UK) using mouse monoclonal
antibodies with no cross-reactivity to insulin and <0.1%
cross-reactivity to split (32,33)-proinsulin. Plasma glu-
cose was measured by a hexokinase method. Serum
high-density lipoprotein (HDL)-cholesterol was mea-
sured after precipitation with manganese heparin and
serum total cholesterol, triglycerides, uric acid, g-gluta-
myl transferase, and creatinine by enzymatic colori-
metric methods, all on a Hitachi 737 Automatic
Analyzer (Boehringer Mannheim, Mannheim, Germany)
with reagents from the same manufacturer. Haemoglo-
bin, white blood cells, and platelets were analysed on a
Coulter Counter (Beckman Coulter, Inc., Miami, FL,
USA with reagents from Beckman Coulter Inc. (Fuller-
ton, CA, USA). HbA1c was measured by an immuno-
turbidimetric method on a Cobas Mira Plus Chemistry
Analyzer (Roche Diagnostics, Basel, Switzerland) with
reagents from the same company. The insulin and
proinsulin samples were frozen at -70°C until analysis
by the Metabolic Laboratory, Institute of Clinical Medi-
cine, University of Tromsø in 1998 and 1999. All other
samples were analysed by the Department of Medical
Biochemistry, University Hospital of Tromsø.
Statistical analyses
We constructed plots for the medians and 25 and 75
percentiles of insulin and proinsulin concentrations, as
well as proinsulin/insulin according to gender and age
group and computed the trends across age for the med-
ians by regression analysis weighted for the inverse of
the squared SEM in each age group. Age-adjusted per-
centages and means were calculated by the direct
method. Age and covariates related to insulin resistance
were considered in several multiple regression models
and the best model identified. The following indepen-
dent variables were examined: age, BMI, height, waist
and hip circumferences, systolic and diastolic blood
pressures, heart rate, total cholesterol, HDL-cholesterol,
triglycerides, glucose, uric acid, creatinine, log10(g-gluta-
myl transferase), white blood cell count, platelet count,
calcium, fibrinogen, haemoglobin, coffee consumption,
total abstinence from alcohol (yes = 1, no = 0), alcohol
intake (times per month), current smoking (yes = 1,
no = 0), use of antihypertensive medication (yes = 1, no
= 0), use of beta blocker (yes = 1, no = 0), hours of light
and strenuous physical activity per week and hours since
the last meal. The final model was then employed with
insulin, proinsulin and proinsulin/insulin as dependent
variables, separately for men and women, and logarith-
mically transformed as the distributions were positively
skewed. The regression coefficients (b) for the associa-
tions of the independent variables with the outcome
variables were determined with the respective 95%
confidence intervals (95% CI). We checked for interac-
tions between age and the other independent variables
by introducing interaction terms, and confirmed that
the model assumptions were fulfilled. The data were
analysed with the SAS 9.2 Statistical Package (SAS Insti-
tute Inc., Cary, NC, USA) and a two-sided p < 0.05 was
considered statistically significant.
Results
Table 1 summarises the mean age and age-adjusted
characteristics of men and women. As illustrated in
Figure 1 the median insulin levels decreased with
advancing age group in men (p = 0.0104), but not in
women (p = 0.5017). However, serum proinsulin (p =
0.0002 for women and p = 0.0066 for men) and proin-
sulin/insulin (p < 0.0001 for women and p = 0.0002 for
men) rose across age strata in both genders. In multiple
regression analysis, log10(insulin) was negatively whereas
log10(proinsulin) and log10(proinsulin/insulin) positively
associated with advancing age in both genders (Tables 2
and 3). Adjustments by HbA1c did not change the asso-
ciations with age. Also, exclusion of either 38 men and
33 women with HbA1c at or above 6.5% (new criterion
for the diagnosis of diabetes mellitus [13]) or 656 men
and 726 women with HbA1c at or above 5.7% (the
lower HbA1c level considered reasonable for identifying
individuals with a high risk of future diabetes [13]) did
not change the results. The significant associations with
age also persisted after exclusion of persons who had
participated in the family intervention trial [11] (data
not shown). In men and women significant positive
relationships were seen between smoking status
and log10(proinsulin/insulin), but not log10(proinsulin).
Elevated log10(proinsulin), but not log10(proinsulin/insu-
lin) or log10(insulin), was associated with increased
serum creatinine. Increased serum triglycerides were
strongly related with elevated log10(insulin) and log10
(proinsulin). Higher log10(insulin) and log10(proinsulin)
were also associated with increased waist circumfer-
ences and log10(g-glutamyl transferase) (Tables 2 and 3).
Log10(insulin) and log10(proinsulin) were positively, but
log10(proinsulin/insulin) inversely related with heart rate
in both genders (Tables 2 and 3). The regression coeffi-
cients for the associations between log10(proinsulin) and
the time since the last meal differed between men and
women (p = 0.0167).
Discussion
In this cross-sectional study of persons without self-
reported diabetes mellitus from the Tromsø Study we
observed a decline in random casual concentrations of
insulin across increasing age groups in men, but not in
women. However, proinsulin levels and proinsulin-to-
insulin ratios increased across age groups in both men
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together with a rise in proinsulin and in the proinsulin-
to-insulin ratios with advancing age, emerged as signifi-
cant after adjustment for the concurrent glucose levels,
the time since the last meal, and covariates related to
insulin sensitivity, which suggests that beta cell function
deteriorates with age.
Cross-sectional data do not automatically allow infer-
ences about changes in insulin and proinsulin over time
or with age, as differences by cross-sectional age groups
could reflect secular as well as age trends. Importantly,
cross-sectional associationsa si nt h ep r e s e n ts t u d y ,a s
opposed to longitudinal data, do not permit conclusions
to be drawn about causality. However, although the data
are not prospective, a large population-based sample of
men and women, a high attendance rate, control of the
numerous confounding factors, and record of the time
since the last meal contribute to the validity of the
results.
Whereas elevated fasting insulin is often considered as
a marker of insulin resistance [14], stimulated insulin
concentrations also convey information about the capa-
city of beta cells to secrete insulin relative to the level of
insulin resistance [15]. Although the earliest secretory
defect in the development of type 2 diabetes is a drop in
the first-phase insulin release, a decreased capacity for
Table 1 Age and age-adjusted characteristics of study subjects (means ± SEM or %).
Men Women
nn
Age (years) 3065 59.6 ± 0.18 3147 60.6 ± 0.18
Serum insulin (pmol L
-1) 3065 74.49 ± 1.64 3147 61.61 ± 1.26
Serum proinsulin (pmol L
-1) 3053 4.18 ± 0.07 3141 3.22 ± 0.06
Plasma glucose (mmol L
-1) 2993 4.80 ± 0.015 3083 4.74 ± 0.013
HbA1c (%) 2830 5.40 ± 0.009 2932 5.44 ± 0.010
BMI (kg m
-2) 3061 25.96 ± 0.06 3141 25.82 ± 0.08
Waist circumference (cm) 3050 94.8 ± 0.17 3123 84.6 ± 0.19
Hip circumference (cm) 3050 103.1 ± 0.11 3123 103.1 ± 0.16
Systolic blood pressure (mmHg) 3062 141.04 ± 0.35 3130 138.52 ± 0.40
Heart rate (beats min
-1) 3062 75.30 ± 0.24 3130 80.12 ± 0.24
Serum total cholesterol (mmol L
-1) 3063 6.50 ± 0.022 3143 6.87 ± 0.024
Serum HDL-cholesterol (mmol L
-1) 3058 1.39 ± 0.007 3141 1.66 ± 0.008
Serum triglycerides (mmol L
-1) 3062 1.62 ± 0.018 3143 1.43 ± 0.014
Serum uric acid (μmol L
-1) 3051 359.9 ± 1.63 3138 277.5 ± 1.30
Serum creatinine (μmol L
-1) 3060 87.9 ± 0.39 3143 70.2 ± 0.23
Serum g-glutamyl transferase (U L
-1) 3063 32.7 ± 0.78 3144 24.3 ± 0.54
White blood cells (10
9 L
-1) 2962 7.07 ± 0.04 3048 6.82 ± 0.03
Platelet count (10
9 L
-1) 2960 239.2 ± 1.1 3049 256.5 ± 1.1
Plasma fibrinogen (g L
-1) 3044 3.34 ± 0.02 3117 3.43 ± 0.01
Time since last meal (h) 3060 2.42 ± 0.04 3130 2.15 ± 0.03
Questionnaire:
Myocardial infarction (%) 3059 9.0 3138 3.0
Angina pectoris (%) 3057 10.7 3142 6.8
Anti-hypertensive medication (%) 3065 13.2 3147 11.9
First degree relative with diabetes (%) 2436 21.7 2329 26.9
Current smoking (%) 3065 34.0 3147 31.5
Coffee consumption (cups day
-1) 3064 6.06 ± 0.07 3145 4.90 ± 0.05
Teetotaller (%) 3063 13.2 3142 25.6
Alcohol intake (glasses month
-1) 3057 3.18 ± 0.09 3132 1.62 ± 0.06
Light physical activity (h week
-1 ) 3046 3.1 3142 3.0
Strenuous physical activity (h week
-1) 3036 1.8 3110 1.5
BMI, body mass index; HDL, high-density lipoprotein
Non-fasting persons without self-reported diabetes mellitus. The Tromsø Study 1994-95
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Page 4 of 9maximal insulin release is seen prior to a reduction of
basal insulin [16]. Due to this sequence of events, an
age-related decline in insulin release might be more
readily identified in non-fasting than in fasting samples.
Whereas fasting insulin levels have been reported to
increase [17] or not to change [18] with age in cross-
sectional studies, a lower post-challenge insulin response
was previously seen in elderly persons in the Baltimore
Longitudinal Study of Aging [6] and in the Hoorn Study
[7]. To our knowledge, the associations of proinsulin
levels with age have not previously been addressed in
population-based studies.
Hyperproinsulinaemia relative to insulin [4,19] indi-
cates impaired processing of proinsulin, which is an
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Figure 1 Medians and 25 and 75 percentiles of serum insulin, proinsulin, and proinsulin/insulin by age. Non-fasting persons without self-
reported diabetes mellitus. The Tromsø Study 1994-95.
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Page 5 of 9early abnormality of beta cell function. Proinsulin con-
centrations are increased relative to insulin in both IGT
[20] and type 2 diabetes [21]. Longitudinal data in older
persons with IGT also indicate that the proinsulin-to-
insulin ratio is a marker for progression to diabetes [22].
In persons with normal glucose tolerance there are con-
flicting results as to whether the proinsulin-to-insulin
ratios increase with age [23-25]. Our results support the
findings of Fritsche [25] andS h i m i z ua n dc o - w o r k e r s
[24], who observed increases parallel with advancing age
Table 2 Results of multiple regression analysis in men, with dependent variables log10(insulin), log10(proinsulin), and
log10(proinsulin/insulin)
Independent variable Log10(insulin) (n = 2839
a)
Model R
2 (adjusted) = 0.39
Log10(proinsulin) (n = 2840
a)
Model R
2 (adjusted) = 0.33
Log10(proinsulin/insulin) (n = 2839
a)
Model R
2 (adjusted) = 0.08
b 95% CI p b 95% CI p b 95% CI p
Age -0.00281 -0.00381, -0.00181 <0.0001 0.00292 0.00194, 0.00390 <0.0001 0.00572 0.00470, 0.00674 <0.0001
BMI 0.01170 0.00625, 0.01715 <0.0001 0.00626 0.00089, 0.01163 0.0223 0.00544 -0.00009, 0.01097 0.0542
Waist circumference 0.00383 0.00171, 0.00595 0.0004 0.00440 0.00230, 0.00650 <0.0001 0.00057 -0.00159, 0.00273 0.6028
Systolic blood pressure -0.00035 -0.00086, 0.00016 0.1719 -0.00034 -0.00085, 0.00017 0.1845 0.00002 -0.00049, 0.00053 0.9533
Heart rate 0.00307 0.00234, 0.00380 <0.0001 0.00165 0.00094, 0.00236 <0.0001 -0.00142 -0.00215, -0.00069 0.0001
Serum total cholesterol -0.01523 -0.02332, -0.00714 0.0002 -0.01603 -0.02401, -0.00805 <0.0001 -0.00076 -0.00899, 0.00747 0.8565
Serum HDL-cholesterol -0.07273 -0.09917, -0.04629 <0.0001 -0.06774 -0.09381, -0.04167 <0.0001 0.00499 -0.02192, 0.03190 0.7164
Serum triglycerides 0.05739 0.04426, 0.07052 <0.0001 0.06133 0.04837, 0.07429 <0.0001 0.00389 -0.00948, 0.01726 0.5680
Serum uric acid 0.00043 0.00029, 0.00057 <0.0001 0.00038 0.00024, 0.00052 <0.0001 -0.00005 -0.00019, 0.00009 0.5196
Serum creatinine 0.00033 -0.00010, 0.00076 0.1324 0.00115 0.00072, 0.00158 <0.0001 0.00082 0.00039, 0.00125 0.0003
Log10(g-glutamyl transferase) 0.09858 0.05903, 0.13813 <0.0001 0.08575 0.04675, 0.12475 <0.0001 -0.01284 -0.05308, 0.02740 0.5317
Serum glucose 0.08659 0.07493, 0.09825 <0.0001 0.05416 0.04267, 0.06565 <0.0001 -0.03244 -0.04430, -0.02058 <0.0001
Time from last meal -0.02926 -0.03314, -0.02538 <0.0001 -0.02782 -0.03164, -0.02400 <0.0001 0.00144 -0.00250, 0.00538 0.4755
Coffee consumption -0.00429 -0.00682, -0.00176 0.0009 -0.00172 -0.00421, 0.00077 0.1772 0.00258 0.00001, 0.00515 0.0500
Current smoking -0.04642 -0.06853, -0.02431 <0.0001 -0.00532 -0.02713, 0.01649 0.6326 0.04105 0.01855, 0.06355 0.0004
Non-fasting persons without self-reported diabetes mellitus. The Tromsø Study 1994-95.
aUsed observations.; b, regression coefficient; 95% CI, 95% confidence interval; BMI, body mass index; HDL, high-density lipoprotein
Table 3 Results of multiple regression analysis in women with dependent variables log10(insulin), log10(proinsulin),
and log10(proinsulin/insulin)
Independent variable Log10(insulin) (n = 2928
a)
Model R
2 (adjusted) = 0.37
Log10(proinsulin) (n = 2928
a)
Model R
2 (adjusted) = 0.31
Log10(proinsulin/insulin) (n = 2927
a)
Model R
2 (adjusted) = 0.10
b 95% CI p b 95% CI p b 95% CI p
Age -0.00404 -0.00496, -0.00312 <0.0001 0.00238 0.00146, 0.00330 <0.0001 0.00642 0.00544, 0.00740 <0.0001
BMI 0.00596 0.00177, 0.01015 0.0053 0.00266 -0.00151, 0.00683 0.2126 -0.00327 -0.00772, 0.00118 0.1494
Waist circumference 0.00333 0.00188, 0.00478 <0.0001 0.00284 0.00139, 0.00429 0.0001 -0.00046 -0.00201, 0.00109 0.5549
Systolic blood pressure 0.00029 -0.00012, 0.00070 0.1678 0.00022 -0.00019, 0.00063 0.3072 -0.00051 -0.00094, -0.00008 0.0229
Heart rate 0.00260 0.00197, 0.00323 <0.0001 0.00125 0.00062, 0.00188 0.0001 -0.00134 -0.00201, -0.00067 0.0001
Serum total cholesterol -0.01216 -0.01904, -0.00528 0.0005 -0.01510 -0.02196, -0.00824 <0.0001 -0.00293 -0.01024, 0.00438 0.4321
Serum HDL-cholesterol -0.02992 -0.05097, -0.00887 0.0054 -0.03564 -0.05665, -0.01463 0.0009 -0.00577 -0.02815, 0.01661 0.6131
Serum triglycerides 0.06114 0.04795, 0.07433 <0.0001 0.06283 0.04966, 0.07600 <0.0001 0.00168 -0.01233, 0.01569 0.8140
Serum uric acid 0.00049 0.00035, 0.00063 <0.0001 0.00056 0.00042, 0.00070 <0.0001 0.00007 -0.00009, 0.00023 0.3785
Serum creatinine 0.00047 -0.00016, 0.00110 0.1489 0.00151 0.00088, 0.00214 <0.0001 0.00105 0.00038, 0.00172 0.0023
Log10(g-glutamyl transferase) 0.08676 0.05236, 0.12116 <0.0001 0.05826 0.02392, 0.09260 0.0009 -0.02875 -0.06530, 0.00780 0.1233
Serum glucose 0.09133 0.08028, 0.10238 <0.0001 0.05747 0.04644, 0.06850 <0.0001 -0.03390 -0.04564, -0.02216 <0.0001
Time from last meal -0.02572 -0.02989, -0.02155 <0.0001 -0.02091 -0.02508, -0.01674 <0.0001 0.00479 0.00034, 0.00924 0.0346
Coffee consumption -0.00322 -0.00626, -0.00018 0.0370 -0.00300 -0.00602, 0.00002 0.0522 0.00022 -0.00299, 0.00343 0.8952
Current smoking -0.04636 -0.06637, -0.02635 <0.0001 -0.01223 -0.03220, 0.00774 0.2302 0.03402 0.01275, 0.05529 0.0017
Non-fasting persons without self-reported diabetes mellitus. The Tromsø Study 1994-95.
aUsed observations; b, regression coefficient; 95% CI, 95% confidence interval; BMI, body mass index; HDL, high-density lipoprotein
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cose load [24,25] and the first phases of insulin release
during hyperglycaemic clamps [25].
Although specific cut-offs for glucose concentrations
have been settled for the diagnosis of diabetes mellitus
[26], a deterioration of glucose control, and eventually
the development of type 2 diabetes, is a process along a
continuous scale. Notably, a proportion of our subjects
probably had unidentified diabetes or IGT, and the
increase in proinsulin/insulin with age observed in this
study could conceivably just reflect the increase in indi-
viduals with abnormal glucose tolerance. However, a
statement from the American Diabetes Association has
recently affirmed that elevated HbA1c levels at or
beyond 6.5% are sufficient to make a diagnosis of dia-
betes mellitus [13], and in addition, a HbA1c range of
5.7 to 6.4 is considered reasonable for identifying indivi-
duals with a high risk for future diabetes to whom the
term prediabetes may be applied [13]. The omission of
subjects with diabetes or prediabetes according to these
definitions did not change the results.
In women, the median insulin levels did not decline
across age groups, and a peak in insulin concentrations
was observed in attendees aged 30-34 years. The men-
strual cycle, pregnancy, and use of oral contraceptives
are factors specific to women in this age group that may
have influenced the insulin levels [27,28]. These issues,
together with the onset of the menopause [27,29] and
the possibility of hormone replacement therapy [29], are
issues that complicate the consideration of the effect of
age on insulin levels in women, and which could not be
addressed in this study.
The amount of insulin released after the stimulus
imposed by a meal varies according to its size and
constitution, and the prevailing glucose concentrations
[ 3 0 ] .C o m p a r e dt og o l ds t a n d a r dm e t h o d st oa s s e s s
beta cell function, even indexes derived from an oral
glucose tolerance test (OGTT) can only explain
27-64% of the variation in estimated beta cell function
[15]. These variations are due to inter-individual differ-
ences in insulin responses from enteric hormones and
neural responses to nutrient ingestion, gastrointestinal
motility and gastric emptying [15,30]. Random insulin
and proinsulin measurements, even if corrected for the
time since the last meal, are certainly not comparable
to those obtained by a standardised meal or an OGTT
to assess beta cell function. Importantly however, non-
fasting blood samples may be more clinically relevant
than fasting specimens, as people remain in the non-
fasting state a large part of the day [31]. Thus, insulin
levels are involved in hypertriglyceridaemia after meals
[32]. This postprandial hypertriglyceridaemia is linked
with increased cardiovascular risk [31], and associated
with abdominal obesity [32] and with increased liver
fat and hepatic insulin resistance [33], as can be
reflected by elevated g-glutamyl transferase [34].
The reasons why older persons should fail to increase
their insulin secretion as much as younger persons in
the face of insulin resistance are incompletely under-
stood. Potential mechanisms are reduced beta cell mass
or limited beta cell function due to islet accumulation of
amyloid, lipotoxicity, the actions of circulating adipocy-
tokines, or a diminished effect of incretin hormones
[4,5]. Alternative explanations for a negative association
between age and serum insulin could be that older peo-
ple preferentially eat meals that are smaller or have a
composition to trigger less insulin release, or have
slower rates of gastric emptying [35] and delayed nutri-
ent absorption. Other causes could be selective mortality
in elderly persons with elevated insulin due to impaired
insulin action, or lower attendance rates in the older age
groups because of illnesses associated with insulin resis-
tance. However, the death rates of this population were
not high enough to allow selective mortality to account
for the results.
Because the fraction of total metabolic clearance
accomplished by the kidneys is greater for proinsulin
than for insulin [36], an age-related decline in renal
function could conceivably have led to increased proin-
sulin concentrations relative to insulin, as we observed
with advancing age. Advanced renal damage may also in
itself affect glucose metabolism and both cause insulin
resistance and impair insulin secretion [37]. However, as
age, BMI, and serum creatinine were included in the
regression equations and the analyses were performed
separately for men and women, we did in effect adjust
for the glomerular filtration rates [38]. Of note, however,
since the half life of insulin and proinsulin are different
[39], the kinetics of insulin differs from that of proinsu-
lin in the postprandial state and direct comparisons of
proinsulin/insulin ratios measured at different time
points has not been validated.
Although smokers have been reported to be insulin
resistant [40], decreased insulin concentrations in smo-
kers have been described previously [7]. Not only did
we observe negative associations between current
smoking and insulin concentrations, but also positive
associations between smoking and proinsulin/insulin.
These observations are consistent with previous find-
ings of diminished insulin secretion in smokers [41]
and an observation in animal models that nicotine may
have a detrimental effect directly on beta cell function
[42].
Resting heart rate can be perceived as an integrated
marker of haemodynamic and autonomic nervous sys-
tem states, and is an independent predictor of cardiovas-
cular disease [43]. Elevated heart rate may reflect a shift
in autonomic balance toward enhanced sympathetic
Bryhni et al. BMC Endocrine Disorders 2010, 10:21
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Page 7 of 9tone [43] and is associated with higher insulin [44] and
proinsulin concentrations [45], as also observed in the
present study. A novel finding of our study is a negative
association in both genders between heart rate and
proinsulin/insulin. This result is consistent with a pre-
vious report of a positive association between heart rate
and the acute insulin response, as measured by a fre-
quently sampled intravenous glucose tolerance test [45].
Conclusions
The concurrent associations of lower insulin and higher
proinsulin and proinsulin/insulin ratio with age in this
cross-sectional study support a view that insulin release
is blunted with advancing age, as marked by impaired
processing of proinsulin to insulin. If taken together
with previous reports [46,47], the data could also sug-
gest that lifestyle interventions could offset beta cell dys-
function in predisposed elderly persons. However, this
question will have to be investigated further.
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